(RS)-7-[1-(Benzofuran-5-ylmethyl)-3-piperidyl]-5-(difluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine

ID: ALA4758766

Chembl Id: CHEMBL4758766

PubChem CID: 162658231

Max Phase: Preclinical

Molecular Formula: C20H19F2N5O

Molecular Weight: 383.40

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)c1cc(C2CCCN(Cc3ccc4occc4c3)C2)n2ncnc2n1

Standard InChI:  InChI=1S/C20H19F2N5O/c21-19(22)16-9-17(27-20(25-16)23-12-24-27)15-2-1-6-26(11-15)10-13-3-4-18-14(8-13)5-7-28-18/h3-5,7-9,12,15,19H,1-2,6,10-11H2

Standard InChI Key:  BEOURKOWEYUKPI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4758766

    ---

Associated Targets(Human)

PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pde10a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (1396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.40Molecular Weight (Monoisotopic): 383.1558AlogP: 4.19#Rotatable Bonds: 4
Polar Surface Area: 59.46Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.49CX LogP: 3.01CX LogD: 1.89
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.45

References

1. Tresadern G,Velter I,Trabanco AA,Van den Keybus F,Macdonald GJ,Somers MVF,Vanhoof G,Leonard PM,Lamers MBAC,Van Roosbroeck YEM,Buijnsters PJJA.  (2020)  [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration.,  63  (21.0): [PMID:33105987] [10.1021/acs.jmedchem.0c01272]

Source